Buyback Spend for Biogen (BIIB)
Buyback Spend for Biogen (BIIB): headline value $0. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
BIIB
Currently viewingBuyback SpendSwitch metric
Latest period
$0
YoY change
N/A
5Y CAGR
-100.0%
Peak year (2020)
$6.68B
Latest annual
$0
Buyback Spend history chart for Biogen (BIIB) from 1989 to 2025
Buyback Spend history table for Biogen (BIIB) from 1989 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $0 | — | ||
| 2024 | $0 | — | ||
| 2023 | $0 | -100.0% | ||
| 2022 | $750.00M | -58.3% | ||
| 2021 | $1.80B | -73.1% | ||
| 2020 | $6.68B | +13.8% | ||
| 2019 | $5.87B | +34.8% | ||
| 2018 | $4.35B | +218.8% | ||
| 2017 | $1.37B | +36.5% | ||
| 2016 | $1.00B | -80.0% | ||
| 2015 | $5.00B | +463.8% | ||
| 2014 | $886.78M | +121.5% | ||
| 2013 | $400.31M | -59.3% | ||
| 2012 | $984.72M | +97.7% | ||
| 2011 | $497.98M | -76.0% | ||
| 2010 | $2.08B | +176.6% | ||
| 2009 | $751.17M | +1.7% | ||
| 2008 | $738.94M | -75.3% | ||
| 2007 | $2.99B | +834.0% | ||
| 2006 | $320.27M | -0.7% | ||
| 2005 | $322.59M | -56.1% | ||
| 2004 | $734.43M | — | ||
| 2003 | $0 | -100.0% | ||
| 2002 | $135.00M | +52.9% | ||
| 2001 | $88.28M | -70.6% | ||
| 2000 | $300.19M | +51.8% | ||
| 1999 | $197.72M | +201.6% | ||
| 1998 | $65.55M | +836.4% | ||
| 1997 | $7.00M | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — |
Buyback Spend values are taken from Biogen's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual buyback spend for Biogen (BIIB) came in at $0.
Through 2020–2025 (5 years), Biogen buyback spend delivered a -100.0% annualised rate; with a net decline across the window.
Between 2020 and 2025, Biogen buyback spend plunged 100.0%, falling from $6.68B to $0.
The dataset's maximum buyback spend sits at $6.68B (2020); the minimum reading of $0 dates to 1989.
Within Healthcare, Biogen (BIIB) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.
Biogen Buyback Spend by Year
Biogen Buyback Spend 2025: $0
Biogen buyback spend in 2025 was $0.
Biogen Buyback Spend 2024: $0
Biogen buyback spend in 2024 was $0.
Biogen Buyback Spend 2023: $0
Biogen buyback spend in 2023 was $0, plunged 100.0% below 2022.
Biogen Buyback Spend 2022: $750.00M
Biogen buyback spend in 2022 was $750.00M, plunged 58.3% below 2021.
Biogen Buyback Spend 2021: $1.80B
Biogen buyback spend in 2021 was $1.80B.
See more financial history for Biogen (BIIB).
Sector peers — Buyback Spend
Companies in the same sector as Biogen, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Biogen's buyback spend?
Latest reported buyback spend for Biogen (BIIB) is $0 (period ending December 31, 2025).
What is the long-term growth rate of Biogen buyback spend?
Biogen (BIIB) buyback spend compound annual growth rate is -100.0% over the most recent 5 years available.
When did Biogen buyback spend hit its highest annual value?
Biogen buyback spend reached its highest annual value of $6.68B in 2020.
What was Biogen buyback spend in 2024?
Biogen (BIIB) buyback spend in 2024 was $0.
What was Biogen buyback spend in 2025?
Biogen (BIIB) buyback spend in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
BIIB Overview
Company profile, financial tools, and key metrics
BIIB Revenue Counter
Earns $311.09 every second. See per minute, hour, and day.
BIIB Earnings Counter
Earns $41.01 per second net profit. See per minute, hour, and day.
BIIB Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
BIIB What If Invested
What if you had invested $1,000? See historical returns from any date.
BIIB How It Makes Money
Discover visual breakdown of $9.81B in revenue — where it comes from and where it goes.
BIIB Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BIIB Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BIIB Daily Price Character
Explosive · 48.1% historical win rate (green days). Streaks & record days.
BIIB Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BIIB Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.